Medication | Ineffective | Best model | Sampling strategy | Mean AUROC (95% CI) | |
---|---|---|---|---|---|
No | Yes | ||||
Abatacept | 212 | 20 | Ridge classifier | RUS | 0.66 (0.54–0.78) |
Adalimumab | 493 | 36 | XG Boost | OVS | 0.70 (0.68–0.74) |
Certolizumab | 150 | 11 | SVC | OVS | 0.84 (0.79–0.89) |
Etanercept | 530 | 23 | RF Classifier | OVS | 0.68 (0.55–0.87) |
Tocilizumab | 339 | 29 | XG Boost | None | 0.72 (0.69–0.77) |